TrialJournal of neuro-oncology2015
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.
Jennie W Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it